sci論文寫作投稿的一點(diǎn)經(jīng)驗(yàn)

關(guān)于SCI投稿的經(jīng)驗(yàn)淺談世界六大檢索系統(tǒng)：美國(guó)《科學(xué)引文索引》〔SCI〕美國(guó)《工程索引》〔EI〕美國(guó)《化學(xué)文摘》〔CA〕英國(guó)《科學(xué)文摘》〔SA〕日本科技文獻(xiàn)速報(bào)〔CBST〕俄羅斯《文摘雜志》〔PЖ[AJ]〕SCI〔ScienceCitationIndex〕簡(jiǎn)介SCI〔ScienceCitationIndex〕：是美國(guó)ISI〔InstituteforscientificInformation〕使用的對(duì)科技刊物和論文進(jìn)行評(píng)價(jià)的一種工具。ISI每年還出版JCR〔《期刊引用報(bào)告》，全稱JournalCitationReports〕。JCR對(duì)包括SCI收錄的3600種期刊在內(nèi)的4700種期刊之間的引用和被引用數(shù)據(jù)進(jìn)行統(tǒng)計(jì)、運(yùn)算，并針對(duì)每種期刊定義了影響因子〔ImpactFactor〕等指數(shù)加以報(bào)道.IF:<3,3~5,5~10,>10主要反映近兩年論文被引用情況。不同學(xué)科不能用來(lái)比較。不同類型刊物也不能用來(lái)比較。

JounalsISSNTotalCitesImpactNEWENGLJME75050.02JAMA-JAMMEDASSOC0098-748411425031.718CELL0092-867414206431.253NATUR96731.43LANCET0140-673614810628.409SCIENC29028.10NATMED1078-895648,63227.55BLOOD0006-497112203210.432PNATLACADSCIUS0189.38DIABETES0012-1797431018.398

幾種國(guó)際核心期刊IF(2008)：

中國(guó)進(jìn)入SCI檢索系統(tǒng)的生物醫(yī)學(xué)雜志(2008)：JournalsIF主辦單位JournalsIF主辦單位ACTAPHARMACOLSIN1.676中國(guó)藥理學(xué)會(huì)CHINESEJCHEMENG0.572BIOMEDENVIRONSCI0.675中國(guó)疾病預(yù)防控制中心CHINESEJCHEMPHYS0.455CHINESEJELECTRON0.148SCICHINASERA0.408中國(guó)科學(xué)院CHINESEJGEOPHYS-CH0.639SCICHINASERB0.552CHINESEJINORGCHEM0.532SCICHINASERC0.661CHINESEJORGCHEM0.662SCICHINASERD0.725CHINESEJPHYS0.27SCICHINASERE0.495CHINESEJPHYSIOL0.655SCICHINASERF0.664CHINESEJPOLYMSCI0.644SCICHINASERG0.973CHINESEJSTRUCCHEM0.643CHINESEMEDJ-PEKING0.858中華醫(yī)學(xué)會(huì)CHINESEANNMATHB0.443CHINESEPHYS1.68中國(guó)科學(xué)院上海生理研究所CHINESECHEMLETT0.488CHINESEPHYSB

CHINESEJANALCHEM0.633CHINESEPHYSC

CHINESEJASTRONAST0.689CHINESEPHYSLETT0.743CHINESEJCATAL0.707CHINESESCIBULL0.683CHINESEJCHEM0.945成功關(guān)鍵：Pathwaystosuccess稿件的質(zhì)量

投稿技巧運(yùn)氣英文論文的撰寫根本思路a〕問(wèn)題X是重要的；b〕前人的工作A、B曾經(jīng)研究過(guò)這個(gè)問(wèn)題；c〕A、B有一些缺陷；d〕我們提出了方法D；e〕對(duì)D進(jìn)行實(shí)驗(yàn)，和A、B進(jìn)行比較；f〕實(shí)驗(yàn)證明D比A、B優(yōu)越；g〕解釋為什么D是更優(yōu)的，而其他的思路〔比方E〕是不行的；h〕闡述D的有效性和局限性；i〕對(duì)D進(jìn)一步開展的討論。英文論文的框架Title:Beshort,accurate,andunambiguous;Giveyourpaperadistinctpersonality;Introduction：Whatisknown;Whatisunknown;Whywedidthisstudy?Methods：Participants,subjects;Measurements;Outcomesandexplanatoryvariables;Statisticalmethods.Results：Samplecharacteristics;Univariateanalyses;Bivariateanalyses;Multivariateanalyses.Tablesandfigures：Nomorethansixtablesorfigures;UseTable1forsamplecharacteristics;Putmostimportantfindingsinafigure.Discussion：Statewhatyoufound;Outlinethestrengthsandlimitationsofthestudy;Discusstherelevancetocurrentliterature;Outlineyourimplicationswithaclear"Sowhat?"and"Wherenow?“References：Allcitationsmustbeaccurate;Includeonlythemostimportant,mostrigorous,andmostrecentliterature;Quoteonlypublishedjournalarticlesorbooks;Neverquote"secondhand";Citeonly20-35references.英文論文寫作的框架要求英文寫作的語(yǔ)言技巧Introduction：

指出當(dāng)前研究的缺乏并有目的地引導(dǎo)出自己研究的重要性：However,littleinformation(littleattention/littlework/littledata/littleresearch……)(orfewstudies/fewinvestigations/fewresearchers/fewattempts……)(orno/noneofthesestudies……)has(have)beendoneon(focusedon/attemptedto/conducted/investigated/studied(withrespectto))。However,dataisstillscarce(rare,lessaccurate)，Weneedto(aimto,haveto)providemoredocuments(data,records,studies,increasethedataset).Furtherstudiesarestillnecessary(essential)……提出自己的觀點(diǎn)：Weaimto//Thispaperreportson//Thispaperprovidesresults//Thispaperextendsthemethod//Thispaperfocuson……Thepurposeofthispaperisto……Furthermore,Moreover,Inaddition,wewillalsodiscuss……提出觀點(diǎn)：不是新觀點(diǎn)：Weconfirmthat……很自信的觀點(diǎn)：Webelievethat……數(shù)據(jù)推斷出一定的結(jié)論：Resultsindicate,infer,suggest,implythat……不完全肯定：Wetentativelyputforward(interrpretethisto…)OrTheresultsmaybedueto(causedby)attributedtoresultedfrom……OrThisisprobablyaconsequenceof……Itseemsthat……canaccountfor(interpret)this……OrItisposiblethatitstemfrom……自我批評(píng)：研究的問(wèn)題有點(diǎn)片面：Itshouldbenotedthatthisstudyhasexamined……Weconcentrate(focus)ononly……Wehavetopointoutthatwedonot……Somelimitationsofthisstudyare……結(jié)論有些缺乏:Theresultsdonotimply……Theresultscannotbeusedtodetermine(orbetakenasevidenceof)……Unfortunately,wecannotdeterminethisfromthisdata……Ourresultsarelackof……Discussion：

英文寫作的語(yǔ)言技巧

英文寫作的語(yǔ)言技巧連接詞與邏輯：常見(jiàn)的連接詞:However,also,inaddition,consequently,afterwards,moreover,Furthermore,further,although,unlike,incontrast,Similarly,Unfortunately,alternatively,parallelresults,Inorderto,despite,Forexample,Comparedwith,otherresults,thus,therefore……按時(shí)間表達(dá)：AAadvocateditforthefirsttime.接下來(lái)可用ThenBBfurtherdemonstratedthat.再接下來(lái)，可用Afterwards,CC……如果還有，可用MorerecentstudiesbyDD…表達(dá)兩種觀點(diǎn):AAputforwardthat……Incontrast,BBbelieveorUnlikeAA,BBsuggestorOnthecontrary(說(shuō)明前面觀點(diǎn)錯(cuò)誤)，如果只說(shuō)明兩種觀點(diǎn)對(duì)立，用incontrastBB……段落布局:Therefore,therearethreeaspectsofthisproblemhavetobeaddressed.Thefirstquestioninvolves……Thesecondproblemrelatesto……Thethirdaspectdealswith……也可以直接用First,Second,Third,Finally……對(duì)前人研究結(jié)果的不認(rèn)同：

Theirstudiesmaybemorereasonableiftheyhad……consideredthissituation.Theirresultscouldbebetterconvincedifthey……Theirconclusionmayremainsomeuncertanties.首先，構(gòu)建論文的框架：各局部大約的段落劃分，各段落所要闡述的內(nèi)容?！彩欠裼斜匾葘懗芍形恼撐模俊抽喿x相關(guān)文獻(xiàn)，在閱讀過(guò)程中，把可能用得到的句子或相關(guān)段落分別黏貼到對(duì)應(yīng)的局部。如果能有幾篇對(duì)口的綜述〔新近發(fā)表的〕，對(duì)于introduction和discussion的寫作能起到事半功倍的效果。如有引文，將出處整理好。寫作素材足夠充分后，挑取相關(guān)度高，引文雜志影響因子高以及出版年份新的論據(jù)用于寫作。句式可根據(jù)段落的構(gòu)建情況稍作改動(dòng)，盡量不要自己造句。對(duì)于描述觀點(diǎn)的句子，盡量要有確切的出處?！膊灰聟⒖嘉墨I(xiàn)多〕總體潤(rùn)色。添加必要的連詞，明晰句子之間的邏輯關(guān)系。把按欲投雜志的要求整理參考文獻(xiàn)。最后寫摘要，致謝等等。初寫者的常用寫作步驟Results盡量要用table,figure表示出來(lái)。文字表達(dá)只是對(duì)圖表的說(shuō)明和補(bǔ)充。Figure一般不要超過(guò)8個(gè)。Results中不要涉及對(duì)結(jié)果的評(píng)論。試驗(yàn)方法要詳實(shí)，所用藥品，試劑一定要注明批號(hào)，生產(chǎn)公司，國(guó)家〕。如果受試對(duì)象為人，一定要注明已通過(guò)倫理委員會(huì)批準(zhǔn)。圖表要求簡(jiǎn)潔，直觀。一般應(yīng)用柱形圖或曲線圖。顯示黑白兩色。要求注明標(biāo)準(zhǔn)差〔誤〕。字體一般應(yīng)用ArialBlack,如文獻(xiàn)中同時(shí)存在幾個(gè)類似的Figure，要求各個(gè)Figure中的字體大小要求一致。如提供免疫組織化學(xué)照片，必須提供陰性對(duì)照。照片要求背景盡量為白色，如一個(gè)Figure中同時(shí)存在數(shù)張免疫組化照片，那么要求背景盡可能一致。Bar一般也是需要提供的。參考文獻(xiàn)要求準(zhǔn)確，有必要通過(guò)pubmed確認(rèn)，尤其從國(guó)內(nèi)文獻(xiàn)摘錄的句子中所帶的參考文獻(xiàn)。時(shí)態(tài)：Thispaperdescribes……Thefocusofthispaperis……Figure1shows幾點(diǎn)本卷須知：

research,study,investigate：research可做名詞、動(dòng)詞，但通常做名詞用，很少見(jiàn)到動(dòng)詞的用法。句中需要?jiǎng)釉~時(shí)常用study或investigate來(lái)表達(dá)。detail/detailed：Thepropertiesofthiscompoundwerestudiedindetail.//Thedetailedpropertiesofthiscompoundwerestudied.//Thedetailsofthepropertiesofthiscompoundwerestudied.follows/following：Theresultsareasfollows:……//Wegotfollowingresults:……increase,decrease：均可做名詞和動(dòng)詞，Wecanobserveanincreaseinthereactionrate.//Thereactionrateincreases.focus,concentrate：focus:n.,v.Thefocusofthispaperis……Thispaperfocuseson……Ourstudyfocuseson……Wefocusourstudyon……Ourstudyisfocusedon……concentrate:v.Weconcentrateourstudyon……Ourstudyisconcentratedon……effect,affect：effect:n.//affect:v.compose,consist：AiscomposedofBandC.//AconsistsofBandC.increase,improve：increase:主要指數(shù)值上的增加。improve:主要指性質(zhì)的增加、改善。

一些常用詞匯用法小結(jié)閱讀文獻(xiàn)。盡量用文獻(xiàn)中的句子。對(duì)于自己造的句子要遵循——短，簡(jiǎn)單，意思明確，語(yǔ)法無(wú)誤。實(shí)驗(yàn)?zāi)康囊?jiǎn)潔明確，一般能說(shuō)明1-2個(gè)問(wèn)題即可。文章結(jié)構(gòu)，段落結(jié)構(gòu)和中心思想。結(jié)果局部不要對(duì)結(jié)果加以評(píng)論。結(jié)論要客觀，用詞不要過(guò)于絕對(duì)。投稿選刊選刊依據(jù)：IF,本領(lǐng)域的影響力，前人投稿經(jīng)驗(yàn)教訓(xùn)，政治因素等等。選擇一個(gè)主投雜志。3-4個(gè)期刊作為候選.最好選擇文章參考文獻(xiàn)中的雜志.投稿的信念：必中懷有僥幸心理稿件準(zhǔn)備嚴(yán)格按照InstructionforAuthor整理文章：5C—correctness、clarity、concision、completionandconsistencyCoverletter：說(shuō)明投稿意愿；簡(jiǎn)要介紹文章內(nèi)容意義；未一稿多投;文稿內(nèi)容真實(shí)，無(wú)作偽；所有作者均已閱讀文稿，且同意送稿；通信作者地址、、Fax、e-mail；通信作者簽名。模板1模板2模板3模板4TITLEPAGEEnhancementoffractionatedbonemarrowtransplantationonhematopoieticcellhominginamiceallogeneicmodel1YingsongXiang1,SupingSun1,JianmingCai1,MingfengXiang2,GushengTang1andXuetaoCao31DepartmentofRadiation&NuclearMedicine,SecondMilitaryMedicalUniversity,800XiangyinRoad,Shanghai200433,.2DepartmentofSurgery,SecondAffiliatedHospital,JiangxiMedicalUniversity,Nanchang331400,P.R.China.3DepartmentofImmunology,SecondMilitaryMedicalUniversity,800XiangyinRoad,Shanghai200433,.Keywords:hematopoieticstemcells,apoptosis,transplantation,stemcellhoming.RunningHead:BonemarrowtransplantationWordCount:Abstract:218;Text:3279有時(shí)需提供Figure和table的accountAddressforCorrespondence:YingsongXiang,DepartmentofRadiationMedicine,SecondMilitaryMedicalUniversity,800XiangyinRoad,Shanghai200433P.R.China.Tel:(+8621)25070357,FAX:(+8621)25070356.E-mail:Footnotes1SupportedbygrantsfromtheNationalNaturalScienceFoundationofChina(39600077and39770329)andtheNationalHighBiotechnologyFoundationofChina(Z200103).AbbreviationsAllo-,allogeneic;BM,bonemarrow;BMC,bonemarrowcells;BMT,bonemarrowtransplantation;CFC,colonyformingcells;CFU,colonyformingunits;Fr-BMT,fractionatedbonemarrowtransplantation;HSC,hematopoieticstemcells;Syn-,syngeneic;UCB,umbilicalcordblood.修稿原那么Pointtopoint.如所提意見(jiàn)具有可行性，盡可能按照審稿人的意思做。如果不可行，說(shuō)明原因。請(qǐng)別人看一遍，防止筆誤和修改不全〔前后不一致〕修稿要及時(shí)返回，不要拖?！惨话阋?個(gè)月之內(nèi))模板1模板2被拒稿端正心態(tài)，高分值雜志的拒稿率超過(guò)70%。對(duì)編輯表示感謝，為下次投稿做鋪墊。迅速轉(zhuǎn)入備選雜志的投稿。原那么上不允許。會(huì)議論文沒(méi)問(wèn)題。國(guó)際已經(jīng)發(fā)表的論文，中華不要投。中華發(fā)表的文章，原那么上不要再投國(guó)外。關(guān)于一稿多投投稿常用術(shù)語(yǔ)Corresponding/correspondenceauthor：通訊作者，負(fù)責(zé)聯(lián)系出版、校稿事宜的作者authorforcopyrequests：副本索取作者academicdegree：學(xué)位，如M.D.,Ph.D.,RNacademictitle：職稱，如教授〔fullprofessor〕，副教授〔associateprofessor〕，教授助理〔assistantprofessor〕，職稱不能作論文署名用acoverletter/lettertotheeditors：附信arunninghead/title：頁(yè)眉標(biāo)題，約5個(gè)英文單詞投稿常用術(shù)語(yǔ)legends：插圖說(shuō)明，應(yīng)與插圖分開，另頁(yè)打印hardcopy:硬文本，即打印或復(fù)印文本，按編輯部要求提供印數(shù)doublespacing：雙行〔打印〕，即送審的英文稿件要以空兩行的格式打印primereviewer/referee：初審者，即負(fù)責(zé)稿件初審的專家，一般3-5人copyrighttransfer：版權(quán)轉(zhuǎn)讓：一般來(lái)說(shuō)，稿件被接受的同時(shí)，其版權(quán)同時(shí)轉(zhuǎn)讓給了該雜志投稿常用術(shù)語(yǔ)authorship：著作權(quán)，參加研究的所有作者，包括沒(méi)有署名的作者，都具有著作權(quán)authorshipresponsibility：作者責(zé)任，有兩層意思：1〕作者必須是參加研究或局部研究的人，對(duì)所作研究是知情的；2〕作者必須對(duì)所做的研究負(fù)責(zé)patients’rightstoprivacy：病人隱私權(quán)informedconsent：知情同意〔書〕，在進(jìn)行新藥，新技術(shù)、新方法的研究時(shí)，必須將研究的有關(guān)事宜告訴病人并經(jīng)病人的同意，在論文中必須對(duì)此有專門說(shuō)明謝謝！Acoverletter〔sample1)DearEditors:WouldyoupleasekindlyacceptourmanuscriptentitledDiscreteeffectsofcardiacnorepinephrineonpost-ischemicmyocardialdysfunctioninhypertensiverats?【投稿愿望】Wethinkthatthemostinterestingresultofthisstudyisthatdifferentdegreesofcardiacnorepienphrinereductioninhypertrophiedheartsledtoquitedifferentpatternsofrecoveryinposat-ischemicheartfunction.Sincereductionofcardiacnorephrinewithreserpinedidnotresultindepressedmyocardialcontractility,itisofpotentialimportancewhensuchinterferenceisutilizedtodeterfurtherdysfunctioninheartsduringischemia.【本研究的意義】

Partsofthepresentresultswerepresentedatthe11thJapan-ChinaJointMeetingonPharmacologyheldinChinaon25-27Aug.2000andwillbepublishedintheformofabstractinthejournalActaPharmacologicaSinicabytheendofthisyear.HereenclosedarethreecopiesoftheabstractsubmittedtoActaPharmacologicaSinica.Thepresentworkisnotcurrentlyunderconsiderationforpublicationelsewhere.【對(duì)內(nèi)容重復(fù)等問(wèn)題加以說(shuō)明】

ThankyouverymuchSincerelyyours,CHENHong,MD,PhD

稿件準(zhǔn)備

Acoverletter〔sample2)DearDr．：EnclosedarethreecopiesofamanuscriptbyRoseN．Dipaola，DonnaA．Gallo，andTomN．Robertstitled”HepatitisCVirusInfectioninLong-TermTransfusionPatients”.Itissubmittedtobeconsideredforpublicationasa”O(jiān)riginalArticle"inyourjournal．Thispaperis～?Neithertheentirepapernoranypartofitscontenthasbeenpublishedorhasbeenacceptedelsewhere.Itisnotbeingsubmittedtoanyotherjournal．WebelievethepapermaybeofparticularinteresttothereadersofyourjournalbecausethestudyitreportsstatedtheHCVinfectionrateamonglong-termtransfusionpatientsishigherthanthatofthegeneralpopulationandofshort-termtransfusionpatients．CorrespondenceandphonecallsaboutthepapershouldbedirectedtoRoseN．Dipaolaatthefollowingaddress，phoneandfaxnumber，ande-mailaddress：RoseN．Dipaola，MDInstituteofInternalMedicineClevelandClinicFoundation9500EuclidAve．Cleveland，OH44195，USATel：1-216-444-5360Fax：1-216-444-9580E-mail：dipao＠cesmtp．ccf.OrgThanksverymuchforyourattentiontoourpaper．Sincerelyyours，RoseN．Dipaola

稿件準(zhǔn)備DearEditors:

Onbehalfofmyco-authors,Iamsubmittingtheenclosedmaterial“TITLE”forpossiblepublicationinJOURNAL.

Wecertifythatwehaveparticipatedsufficientlyintheworktotak